Section 32-41ll - (Formerly Sec. 19a-32f). Development of donated funds program to encourage regenerative medicine research. Administration of Regenerative Medicine Research Fund(a) The chief executive officer of Connecticut Innovations, Incorporated, shall (1) develop a donated funds program to encourage the development of funds other than state appropriations for regenerative medicine research in the state, (2) examine and identify specific ways to improve and promote for-profit and not-for-profit regenerative medicine research and research in related areas in the state, including, but not limited to, identifying both public and private funding sources for such research, maintaining existing regenerative medicine-related businesses, recruiting new regenerative medicine-related businesses to the state and recruiting scientists and researchers in such field to the state, (3) administer a regenerative medicine research assistance program that shall provide financial assistance to eligible institutions for the advancement of regenerative medicine research in the state pursuant to section 32-41kk, (4) monitor the regenerative medicine research conducted by eligible institutions that receive such financial assistance, and (5) prepare a comprehensive strategic plan for the Regenerative Medicine Research Fund, established pursuant to section 32-41kk, and financial assistance awarded from said fund that shall include, but need not be limited to, identification of specific methods or strategies to (A) achieve the scientific and economic development objective of said fund, (B) build innovation capacity, and (C) sustain investments of moneys received by said fund.(b) Connecticut Innovations, Incorporated, shall serve as administrator of the Regenerative Medicine Research Fund and shall: (1) Develop the application for the financial assistance authorized under subsection (b) of section 32-41kk; (2) review such applications; (3) review recommendations of peer reviewers pursuant to section 32-41mm;(4) prepare and execute any assistance agreements or other agreements in connection with the awarding of such financial assistance;(5) develop performance metrics and systems to collect data from recipients of such financial assistance; and(6) collect information from such recipients concerning each recipient's employment statistics, business accomplishments and performance outcomes, peer review articles and papers published, partnerships and collaborations with other entities, licenses, patents and invention disclosures, scientific progress as it relates to the commercialization of intellectual property funded by such financial assistance, efforts to commercialize such intellectual property, and other funds received for research.Conn. Gen. Stat. § 32-41ll
( P.A. 05-149 , S. 3 ; P.A. 06-33 , S. 1 ; P.A. 10-117 , S. 43 ; P.A. 11-242 , S. 39 ; P.A. 14-98 , S. 34 ; P.A. 15-55 , S. 1 ; 15-222 , S. 3 .)
Amended by P.A. 23-0204, S. 240 of the Connecticut Acts of the 2023 Regular Session, eff. 7/1/2023.Amended by P.A. 15-0222, S. 3 of the Connecticut Acts of the 2015 Regular Session, eff. 7/1/2015.Amended by P.A. 15-0055, S. 1 of the Connecticut Acts of the 2015 Regular Session, eff. 6/19/2015.Amended by P.A. 14-0098, S. 34 of the Connecticut Acts of the 2014 Regular Session, eff. 10/1/2014.Amended by P.A. 11-0242, S. 39 of the the 2011 Regular Session, eff. 10/1/2011.Amended by P.A. 10-0117, S. 43 of the February 2010 Regular Session, eff. 10/1/2010.